Increasing the value
of genetic testing.
Accurate results
through cutting-edge
NGS testing.
We offer comprehensive neurogenetic testing, backed by a multidisciplinary team of clinical neurology experts, laboratory scientists, and genetic counselors, to provide the highest standard for mutation detection and depth of coverage. No other laboratory matches the breadth of our testing, which can help facilitate interpretations by recommending confirmatory testing for variants of unknown or unclear significance.
Our neurogenetic testing focuses on some of the most common hereditary neurological conditions. We increase the value of genetic testing by only including genes with clinical significance and by using an algorithmic approach to testing to save money and ensure the highest level of care.
World-class
testing
Our testing was designed to focus on depth of coverage to ensure that we will find any genetic variants present. We offer testing with 3–5x more depth of coverage than the industry standard to give you peace of mind with negative test results.
Genes with clinical significance
Our genetic tests are built based on a well-curated panel of genes. We focus on genes with clinical significance that are known to play a role in neurologic disease. By targeting important genes, we eliminate variants of unknown significance and therefore eliminate confusing results
A focus on test utilization
We believe in an algorithmic and phenotypic approach to test ordering that focuses on providing the right test for the right patient. By using this approach, clinicians get answers for their patients in the most efficient way, saving time and money for their institution.
Additional Resources
Nicole Boczek, Ph.D., co-director of Mayo Clinic's Genetics and Genomics Laboratory, explains the innovative new hereditary hearing loss panel now available through Mayo Clinic Laboratories. This comprehensive panel analyzes 160 genes associated with hereditary hearing loss, assessing for both nonsyndromic hearing loss, as well as syndromic hearing loss, which can be difficult to recognize clinically.
The diagnosis of mitochondrial disease can be particularly challenging as the presentation can occur at any age, involve virtually any organ system, and be associated with widely varying severities. Due to the considerable overlap in the clinical phenotypes of various mitochondrial disorders, it is often difficult to distinguish these specific inherited disorders without genetic testing.
Christopher Klein, M.D., and Erik Thorland, Ph.D., give an overview of the new hereditary epilepsy panels available through Mayo Clinic Laboratories. They discuss the Mayo Clinic testing approach, interpretation and results, and custom gene ordering.
This "Specialty Testing" webinar will outline the benefits and limitations of genetic testing for neurologic disorders and provide a framework for interpretation of test results.
Life with an inherited disease sometimes brings unexpected twists and turns. Learn how five-year-old Gus Erickson has navigated the gyrations with the help of Mayo Clinic’s Neurofibromatosis Clinic.